Gray Market Peptides: So Much Hype, So Little Data Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non lesional and lesional skin Annals of the Rheumatic Diseases Internet famous peptides like BPC 157 and TB 500 might be the future, but right now they're a shot in the dark. BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options Alterations of gut microbiota for the onset and treatment of psoriasis: A systematic review ScienceDirect